Azar Calls For Transparency And Other Reforms In 340B Program

July 11, 2018
HHS Secretary Alex Azar on Monday (July 9) called for increasing transparency in the 340B program, as well as reducing the gap between what providers pay and how much they are reimbursed for drugs in the discount program. Azar also told stakeholders at a 340B Coalition conference that the ceiling price and penalties rule was not delayed out of deference to the pharmaceutical industry, but because the administration wants to reform the 340B program as part of its comprehensive approach...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.